SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: stock bull who wrote (2363)4/8/1998 4:05:00 PM
From: Tim C. Lienau  Read Replies (1) of 3725
 
Thanks for the response, I feel that through studies wonderful cases can be made for the use of this technology, but in the U.S. the insurance companies who are the gate keepers with doctors are educated it does not matter what your offering. This reminds me of the hurdles that any alternative medicine has to jump, gain user acceptance, then watch the stock price go. My question is then, what has management done to effectively offer their product to the largest health care market on the planet? T. Lienau
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News